Zacks Research Issues Positive Forecast for TriMas Earnings

TriMas Co. (NASDAQ:TRSFree Report) – Analysts at Zacks Research lifted their Q4 2024 earnings per share (EPS) estimates for shares of TriMas in a research report issued to clients and investors on Monday, January 27th. Zacks Research analyst M. Das now anticipates that the industrial products company will post earnings of $0.48 per share for the quarter, up from their prior forecast of $0.47. The consensus estimate for TriMas’ current full-year earnings is $1.69 per share. Zacks Research also issued estimates for TriMas’ Q3 2025 earnings at $0.59 EPS, Q4 2026 earnings at $0.50 EPS and FY2026 earnings at $2.10 EPS.

TriMas (NASDAQ:TRSGet Free Report) last announced its quarterly earnings data on Monday, November 4th. The industrial products company reported $0.43 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.57 by ($0.14). TriMas had a net margin of 2.93% and a return on equity of 9.21%. The company had revenue of $229.36 million for the quarter, compared to analysts’ expectations of $239.33 million. During the same quarter in the previous year, the firm posted $0.57 EPS. The firm’s quarterly revenue was down 2.5% compared to the same quarter last year.

Several other research analysts have also recently issued reports on the stock. BWS Financial reaffirmed a “buy” rating and issued a $40.00 target price on shares of TriMas in a report on Thursday, January 23rd. StockNews.com upgraded shares of TriMas from a “sell” rating to a “hold” rating in a report on Wednesday, November 13th.

View Our Latest Stock Report on TRS

TriMas Stock Performance

Shares of TriMas stock opened at $24.47 on Wednesday. TriMas has a 1 year low of $22.24 and a 1 year high of $28.51. The firm’s 50-day moving average is $24.99 and its 200 day moving average is $25.44. The stock has a market cap of $992.75 million, a price-to-earnings ratio of 38.23 and a beta of 0.67. The company has a debt-to-equity ratio of 0.60, a current ratio of 2.83 and a quick ratio of 1.44.

Institutional Trading of TriMas

A number of institutional investors have recently made changes to their positions in TRS. Algert Global LLC lifted its position in TriMas by 4.2% during the second quarter. Algert Global LLC now owns 15,779 shares of the industrial products company’s stock valued at $403,000 after purchasing an additional 639 shares during the period. FMR LLC raised its stake in TriMas by 1.7% during the 3rd quarter. FMR LLC now owns 44,082 shares of the industrial products company’s stock valued at $1,125,000 after buying an additional 729 shares during the last quarter. JPMorgan Chase & Co. lifted its holdings in shares of TriMas by 3.3% during the 3rd quarter. JPMorgan Chase & Co. now owns 38,461 shares of the industrial products company’s stock valued at $982,000 after buying an additional 1,227 shares during the period. Inspire Investing LLC lifted its holdings in shares of TriMas by 17.4% during the 3rd quarter. Inspire Investing LLC now owns 16,155 shares of the industrial products company’s stock valued at $412,000 after buying an additional 2,389 shares during the period. Finally, Creative Planning boosted its stake in shares of TriMas by 11.0% in the 2nd quarter. Creative Planning now owns 27,056 shares of the industrial products company’s stock worth $692,000 after buying an additional 2,681 shares during the last quarter. Hedge funds and other institutional investors own 99.42% of the company’s stock.

About TriMas

(Get Free Report)

TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.

See Also

Earnings History and Estimates for TriMas (NASDAQ:TRS)

Receive News & Ratings for TriMas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TriMas and related companies with MarketBeat.com's FREE daily email newsletter.